antidote
United States
| Agent | Usage | RND | Rating2.0 | ACS | K:D | ADR | KAST | KPR | APR | FKPR | FDPR | K | D | A | FK | FD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1 (14%) | 23 | 0.91 | 195.0 | 0.89 | 116.0 | 70.0% | 0.74 | 0.22 | 0.04 | 0.09 | 17 | 19 | 5 | 1 | 2 |
|
1 (14%) | 17 | 0.88 | 185.0 | 0.67 | 124.0 | 41.0% | 0.59 | 0.18 | 0.0 | 0.06 | 10 | 15 | 3 | 0 | 1 |
|
1 (14%) | 18 | 0.88 | 181.0 | 0.73 | 125.0 | 50.0% | 0.61 | 0.22 | 0.06 | 0.06 | 11 | 15 | 4 | 1 | 1 |
|
1 (14%) | 14 | 0.53 | 120.0 | 0.46 | 81.0 | 57.0% | 0.43 | 0.07 | 0.0 | 0.0 | 6 | 13 | 1 | 0 | 0 |
|
2 (29%) | 35 | 0.4 | 112.9 | 0.35 | 75.7 | 54.2% | 0.34 | 0.26 | 0.0 | 0.09 | 12 | 34 | 9 | 0 | 3 |
|
1 (14%) | 19 | 0.37 | 110.0 | 0.35 | 69.0 | 68.0% | 0.32 | 0.37 | 0.05 | 0.05 | 6 | 17 | 7 | 1 | 1 |